Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Scheiblhofer

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Delivery|June 21, 2016
Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platformSandra Scheiblhofer, Yoan Machado, Andrea Feinle, et al.
Vaccine|May 5, 2010
Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42)Richard Weiss, Maximilian Gabler, Thomas Jacobs, et al.
International Archives of Allergy and Immunology|March 15, 2006
Is genetic vaccination against allergy possible?Richard Weiss, Sandra Scheiblhofer, Maximilian Gabler, et al.
Vaccine|January 1, 2013
Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated microporesMichael Hessenberger, Richard Weiss, Esther E Weinberger, et al.
Vaccine|January 25, 2017
Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantationSandra Scheiblhofer, Anna Strobl, Veronika Hoepflinger, et al.
Microbes and Infection|August 28, 2003
A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responsesSandra Scheiblhofer, Richard Weiss, Hans Dürnberger, et al.
Vaccine|October 27, 2006
Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasisRichard Weiss, Sandra Scheiblhofer, Josef Thalhamer, et al.
Current Drug Targets. Inflammation and Allergy|October 27, 2005
Design of protective and therapeutic DNA vaccines for the treatment of allergic diseasesRichard Weiss, Peter Hammerl, Arnulf Hartl, et al.
Vaccine|December 9, 2019
Mast cells and γδ T cells are largely dispensable for adaptive immune responses after laser-mediated epicutaneous immunizationIsabella A Joubert, Daniel Kovacs, Sandra Scheiblhofer, et al.
Molecular Immunology|October 31, 2006
Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapySandra Scheiblhofer, Angelika Stoecklinger, Christina Gruber, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Delivery|June 21, 2016
Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platformSandra Scheiblhofer, Yoan Machado, Andrea Feinle, et al.
Vaccine|May 5, 2010
Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42)Richard Weiss, Maximilian Gabler, Thomas Jacobs, et al.
International Archives of Allergy and Immunology|March 15, 2006
Is genetic vaccination against allergy possible?Richard Weiss, Sandra Scheiblhofer, Maximilian Gabler, et al.
Vaccine|January 1, 2013
Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated microporesMichael Hessenberger, Richard Weiss, Esther E Weinberger, et al.
Vaccine|January 25, 2017
Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantationSandra Scheiblhofer, Anna Strobl, Veronika Hoepflinger, et al.
Microbes and Infection|August 28, 2003
A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responsesSandra Scheiblhofer, Richard Weiss, Hans Dürnberger, et al.
Vaccine|October 27, 2006
Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasisRichard Weiss, Sandra Scheiblhofer, Josef Thalhamer, et al.
Current Drug Targets. Inflammation and Allergy|October 27, 2005
Design of protective and therapeutic DNA vaccines for the treatment of allergic diseasesRichard Weiss, Peter Hammerl, Arnulf Hartl, et al.
Vaccine|December 9, 2019
Mast cells and γδ T cells are largely dispensable for adaptive immune responses after laser-mediated epicutaneous immunizationIsabella A Joubert, Daniel Kovacs, Sandra Scheiblhofer, et al.
Molecular Immunology|October 31, 2006
Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapySandra Scheiblhofer, Angelika Stoecklinger, Christina Gruber, et al.
Pageof 7